Effect	effect	O	O
of	of	O	O
humoral	humoral	O	O
modulators	modulators	S_chemicals	O
of	of	O	O
morphine-induced	morphine-induced	O	O
increase	increase	O	O
in	in	O	O
locomotor	locomotor	O	O
activity	activity	O	O
of	of	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
effect	effect	O	O
of	of	O	O
humoral	humoral	O	O
modulators	modulators	S_chemicals	O
on	on	O	O
the	the	O	O
morphine-induced	morphine-induced	O	O
increase	increase	O	O
in	in	O	O
locomotor	locomotor	O	O
activity	activity	O	O
of	of	O	O
mice	mice	O	O
was	was	O	O
studied	studied	O	O
.	.	O	O

The	the	O	O
subcutaneous	subcutaneous	O	O
administration	administration	O	O
of	of	O	O
10	10	O	O
mg/kg	mg/kg	O	O
of	of	O	O
morphine-HC1	morphine-hc1	O	O
produced	produced	O	O
a	a	O	O
marked	marked	O	O
increase	increase	O	O
in	in	O	O
locomotor	locomotor	O	O
activity	activity	O	O
in	in	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
morphine-induced	morphine-induced	O	O
hyperactivity	hyperactivity	O	O
was	was	O	O
potentiated	potentiated	O	O
by	by	O	O
scopolamine	scopolamine	S_chemicals	O
and	and	O	O
attenuated	attenuated	O	O
by	by	O	O
physostigmine	physostigmine	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
,	,	O	O
both	both	O	O
methscopolamine	methscopolamine	S_chemicals	O
and	and	O	O
neostigmine	neostigmine	S_chemicals	O
,	,	O	O
which	which	O	O
do	do	O	O
not	not	O	O
penetrate	penetrate	O	O
the	the	O	O
blood-brain	blood-brain	O	O
barrier	barrier	O	O
,	,	O	O
had	had	O	O
no	no	O	O
effect	effect	O	O
on	on	O	O
the	the	O	O
hyperactivity	hyperactivity	O	O
produced	produced	O	O
by	by	O	O
morphine	morphine	S_chemicals	O
.	.	O	O

Pretreatment	pretreatment	O	O
of	of	O	O
mice	mice	O	O
with	with	O	O
alpha-methyltyrosine	alpha-methyltyrosine	S_chemicals	O
(	(	O	O
20	20	O	O
mg/kg	mg/kg	O	O
i.p	i.p	O	O
.	.	O	O
,	,	O	O
one	one	O	O
hour	hour	O	O
)	)	O	O
,	,	O	O
an	an	O	O
inhibitor	inhibitor	O	O
of	of	O	O
tyrosine	tyrosine	B_chemicals	O
hydroxylase	hydroxylase	S_chemicals	O
,	,	O	O
significantly	significantly	O	O
decreased	decreased	O	O
the	the	O	O
activity-increasing	activity-increasing	O	O
effects	effects	O	O
of	of	O	O
morphine	morphine	S_chemicals	O
.	.	O	O

On	on	O	O
the	the	O	O
other	other	O	O
hand	hand	O	O
,	,	O	O
pretreatment	pretreatment	O	O
with	with	O	O
p-chlorophenylalamine	p-chlorophenylalamine	O	O
(	(	B_chemicals	O
3	3	I_chemicals	O
X	x	O	O
320	320	O	O
mg/kg	mg/kg	O	O
i.p	i.p	O	O
.	.	O	O
,	,	O	O
24	24	O	O
hr	hr	O	O
)	)	O	O
,	,	O	O
a	a	O	O
serotonin	serotonin	S_chemicals	O
depletor	depletor	O	O
,	,	O	O
caused	caused	O	O
no	no	O	O
significant	significant	O	O
change	change	O	O
in	in	O	O
the	the	O	O
hyperactivity	hyperactivity	O	O
.	.	O	O

The	the	O	O
study	study	O	O
suggests	suggests	O	O
that	that	O	O
the	the	O	O
activity-increasing	activity-increasing	O	O
effects	effects	O	O
of	of	O	O
morphine	morphine	S_chemicals	O
are	are	O	O
mediated	mediated	O	O
by	by	O	O
the	the	O	O
release	release	O	O
of	of	O	O
catecholamines	catecholamines	S_chemicals	O
from	from	O	O
adrenergic	adrenergic	S_chemicals	O
neurons	neurons	O	O
in	in	O	O
the	the	O	O
brain	brain	O	O
.	.	O	O
And	and	O	O
the	the	O	O
results	results	O	O
are	are	O	O
consistent	consistent	O	O
with	with	O	O
the	the	O	O
hypothesis	hypothesis	O	O
that	that	O	O
morphine	morphine	S_chemicals	O
acts	acts	O	O
by	by	O	O
retarding	retarding	O	O
the	the	O	O
release	release	O	O
of	of	O	O
acetylcholine	acetylcholine	S_chemicals	O
at	at	O	O
some	some	O	O
central	central	O	O
cholinergic	cholinergic	S_chemicals	O
synapses	synapses	O	O
.	.	O	O

It	it	O	O
is	is	O	O
also	also	O	O
suggested	suggested	O	O
from	from	O	O
collected	collected	O	O
evidence	evidence	O	O
that	that	O	O
the	the	O	O
activity-increasing	activity-increasing	O	O
effects	effects	O	O
of	of	O	O
morphine	morphine	S_chemicals	O
in	in	O	O
mice	mice	O	O
are	are	O	O
mediated	mediated	O	O
by	by	O	O
mechanisms	mechanisms	O	O
different	different	O	O
from	from	O	O
those	those	O	O
which	which	O	O
mediate	mediate	O	O
the	the	O	O
activity-increasing	activity-increasing	O	O
effects	effects	O	O
of	of	O	O
morphine	morphine	S_chemicals	O
in	in	O	O
rats	rats	O	O
.	.	O	O

